脑中eicosanoids的复杂作用:对脑瘤发展和治疗机会的影响
Hsien-Chung Chen1, Wen-Chang Chang2, Jian-Ying Chuang3
1Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan; Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei 110, Taiwan; TMU Research Center of Neuroscience, Taipei Medical University, Taipei 110, Taiwan.
Biochimica et biophysica acta. Reviews on cancer
|July 24, 2023
概括
对于大脑功能至关重要的伊可索类药物,与大脑瘤的生长和对治疗的抵抗有关. 向eicosanoid通路为新的脑瘤治疗和免疫疗法提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 伊可索诺酸是生物活性脂质,对神经元信号传递和血流调节等大脑功能至关重要.
- 主要来源于酸,前列腺素 (PG) 和白血 (LTs) 是关键的大脑eicosanoids调节生理和病理过程.
研究的目的:
- 调查eicosanoids在脑瘤发育,进展和治疗耐药性的作用.
- 探索针对脑瘤的诊断,预后和治疗策略的eicosanoid途径的潜力.
主要方法:
- 关于eicosanoid参与大脑生理学和病理学的文献综述.
- 对瘤细胞增殖,迁移,入侵,血管生成和治疗耐药性的eicosanoid介导促进研究的分析.
- 检查循环氧化酶 (COX) - 2和5-脂氧化酶 (LOX) 抑制剂对脑瘤细胞的影响.
主要成果:
- 伊可索类细胞的失调与诸如质母细胞瘤 (GBM),脑膜瘤和脑膜母细胞瘤等脑瘤有关.
- 乙类,特别是PGE2,增强了GBM细胞的存活率和抗化疗能力.
- 抑制COX-2和5-LOX的药物已证明在减少GBM生长和侵袭性方面具有有效性.
结论:
- 埃可索诺伊德在脑瘤中起着复杂的作用,促进关键的瘤过程并影响治疗结果.
- 向eicosanoid通路为开发包括免疫疗法在内的新型脑瘤疗法提供了有希望的途径.
- 进一步研究eicosanoid在大脑健康和疾病中的功能对于推进治疗策略至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:27Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K